Postoperative adjuvant hepatic arterial infusion chemotherapy (HAIC) with FOLFOX to improve outcomes of patients with hepatocellular carcinoma with microvascular invasion: A prospective multicenter, phase 3, randomized, controlled clinical trial.

被引：0
|
作者：
Li, Shaohua
Mei, Jie
Cheng, Yuan
Li, Qiang
Wang, Qiaoxuan
Fang, Chongkai
Lei, Qiucheng
Huang, Huakun
Cao, Mingrong
Luo, Rui
Deng, Jingduo
Jiang, Yuchuan
Zhao, Rongce
Lu, Lianghe
Zou, Jingwen
Zheng, Lie
Wei, Wei
Chen, Huanwei
Zhong, Chong
Guo, Rongping
机构：
[1] Sun Yat sen Univ Canc Ctr, Guangzhou, Peoples R China
[2] Southern Med Univ, Zhujiang Hosp, Dept Hepatobiliary 2, Guangzhou, Peoples R China
[3] Jinan Univ, Affiliated Hosp 1, Guangzhou, Peoples R China
[4] Sun Yat Sen Univ Canc Ctr, Dept Radiat Oncol, Collaborat Innovat Ctr Canc Med, State Key Lab oratory Oncol South China, Guangzhou, Peoples R China
[5] Guangzhou Univ Chinese Med, Dept Hepatobiliary Surg, Affiliated Hosp1, Guangzhou, Peoples R China
[6] Southern Med Univ, Dept Hepatobiliary Surg 2, Zhujiang Hosp, Guangzhou, Peoples R China
[7] Jinan Univ, Affiliated Hosp 1, Dept Gen Surg, Guangzhou, Peoples R China
[8] Sun Yat sen Univ Canc Ctr, Dept Imaging, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Peoples R China
[9] First Peoples Hosp Foshan, Foshan, Peoples R China
[10] Guangzhou Uni vers Chinese, Affiliated Hosp 1, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4013
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Prophylactic hepatic arterial infusion chemotherapy for the prevention of liver metastasis in patients with colon carcinoma - A randomized controlled trial
    Sadahiro, S
    Suzuki, T
    Ishikawa, K
    Yasuda, S
    Tajima, T
    Makuuchi, H
    Saitoh, T
    Murayama, C
    CANCER, 2004, 100 (03) : 590 - 597
  • [22] HIGH DOSE VERSUS LOW DOSE HEPATIC ARTERIAL INFUSION CHEMOTHERAPY FOR INTRACTABLE, ADVANCED HEPATOCELLULAR CARCINOMA - PROSPECTIVE RANDOMIZED TRIAL
    Bac, S. H.
    Woo, H. Y.
    Choi, J. Y.
    Yoon, S. K.
    Kim, S. G.
    Kim, Y. S.
    Park, J. Y.
    Han, K. H.
    Jang, B. K.
    Hwang, J. S.
    Cheong, J. Y.
    Cho, S. W.
    Seo, Y. S.
    Yim, H. J.
    Um, S. H.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S303 - S304
  • [23] Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: A phase 3, multicenter, randomized controlled trial.
    Ma, Jun
    Chen, Yu-Pei
    Sun, Ying
    Zhou, Qin
    Yang, Kun-Yu
    Jin, Feng
    Zhu, Xiao-Dong
    Shi, Mei
    Hu, Guoqing
    Sun, Yan
    Wu, Hong-Fen
    Wu, Hui
    Lin, Qin
    Wang, Hui
    Tian, Ye
    Zhang, Ning
    Wang, Xicheng
    Shen, Liangfang
    Xie, Fangyun
    Liu, Xu
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [24] Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety
    Wei, Wei
    Jian, Pei-En
    Li, Shao-Hua
    Guo, Zhi-Xing
    Zhang, Yong-Fa
    Ling, Yi-Hong
    Lin, Xiao-Jun
    Xu, Li
    Shi, Ming
    Zheng, Lie
    Chen, Min-Shan
    Guo, Rong-Ping
    CANCER COMMUNICATIONS, 2018, 38
  • [25] Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy(HAIC) Combined with PD-1 Inhibitors for Advanced Hepatocellular Carcinoma with Macrovascular Invasion: A Multicenter Propensity Score Matching Analysis
    Zhang, Fengtao
    Zhong, Sheng
    Wei, Qiming
    Zhang, Haiming
    Hu, Honglei
    Zeng, Bicheng
    Zheng, Xiang
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2024, 11 : 1961 - 1978
  • [26] Hepatic artery infusion chemotherapy (HAIC) combined with sintilimab and bevacizumab biosimilar (IBI305) for initial unresectable hepatocellular carcinoma (HCC): A prospective, single-arm phase II trial.
    Liu, Dongming
    Mu, Han
    Liu, Changfu
    Zhang, Weihao
    Cui, Yunlong
    Wu, Qiang
    Zhu, Xiaolin
    Fang, Feng
    Zhang, Wei
    Xing, Wenge
    Li, Qiang
    Song, Tianqiang
    Lu, Wei
    Li, Huikai
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [27] Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial
    Ikeda, M.
    Shimizu, S.
    Sato, T.
    Morimoto, M.
    Kojima, Y.
    Inaba, Y.
    Hagihara, A.
    Kudo, M.
    Nakamori, S.
    Kaneko, S.
    Sugimoto, R.
    Tahara, T.
    Ohmura, T.
    Yasui, K.
    Sato, K.
    Ishii, H.
    Furuse, J.
    Okusaka, T.
    ANNALS OF ONCOLOGY, 2016, 27 (11) : 2090 - 2096
  • [28] PROSPECTIVE RANDOMIZED CONTROLLED PHASE III TRIAL COMPARING THE EFFICACY OF SORAFENIB VERSUS SORAFENIB IN COMBINATION WITH LOW-DOSE CISPLATIN/FLUOROURACIL HEPATIC ARTERIAL INFUSION CHEMOTHERAPY IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA
    Kudo, M.
    Ueshima, K.
    Yokosuka, O.
    Obi, S.
    Izumi, N.
    Aikata, H.
    Nagano, H.
    Hatano, E.
    Sasaki, Y.
    Hino, K.
    Kumada, T.
    Yamamoto, K.
    Imai, Y.
    Iwadou, S.
    Ogawa, C.
    Okusaka, T.
    Arai, Y.
    Kanai, F.
    Akazawa, K.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S209 - S210
  • [29] Multicenter Phase II trial of lenvatinib plus hepatic intra-arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma: LEOPARD
    Ikeda, Masafumi
    Yamashita, Tatsuya
    Ogasawara, Sadahisa
    Kudo, Masatoshi
    Inaba, Yoshitaka
    Morimoto, Manabu
    Tsuchiya, Kaoru
    Shimizu, Satoshi
    Kojima, Yasushi
    Hiraoka, Atsushi
    Nouso, Kazuhiro
    Aikata, Hiroshi
    Numata, Kazushi
    Sato, Tosiya
    Okusaka, Takuji
    Furuse, Junji
    LIVER CANCER, 2024, 13 (02) : 193 - 202
  • [30] Multicenter phase II trial of lenvatinib plus hepatic intra-arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma: LEOPARD
    Ikeda, M.
    Yamashita, T.
    Ogasawara, S.
    Kudo, M.
    Inaba, Y.
    Morimoto, M.
    Tsuchiya, K.
    Shimizu, S.
    Kojima, Y.
    Hiraoka, A.
    Nouso, K.
    Aikata, H.
    Numata, K.
    Sato, T.
    Okusaka, T.
    Furuse, J.
    ANNALS OF ONCOLOGY, 2021, 32 : S821 - S822
12345